Product Description
Alprazolam is also sometimes used to treat depression, fear of open spaces (agoraphobia), and premenstrual syndrome. Talk to your doctor about the possible risks of using this medication for your condition. Alprazolam comes as a tablet, an extended-release tablet, an orally disintegrating tablet (tablet that dissolves quickly in the mouth), and a concentrated solution (liquid) to take by mouth. (Sourced from: https://medlineplus.gov/druginfo/meds/a684001.html)
Mechanisms of Action: C3 Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Approved
Approved Countries: Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: UCB
Company Location: SMYRNA GA 30080
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: Australia, Bulgaria, China, Czech Republic, France, Germany, Hungary, India, Italy, Japan, Poland, Spain, Thailand, Ukraine, United Kingdom, United States, Unknown Location
Active Clinical Trial Count: 11
Highest Development Phases
Phase 3: Epilepsy|Seizures|Status Epilepticus
Phase 1: Cervical Cancer|Healthy Volunteers|Uterine Cancer
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| EP0165 | P3 |
Enrolling by invitation |
Status Epilepticus |
2028-11-30 |
|
| KRC-01-C01 | P1 |
Not yet recruiting |
Uterine Cancer|Cervical Cancer |
2027-01-30 |
|
| EP0165 | P3 |
Unknown Status |
Seizures |
2026-05-22 |
|
| EP0162 | P3 |
Unknown Status |
Seizures |
2026-04-07 |